| The regulation of nanomaterials and nanomedicines for clinical application: current and future perspectives R Foulkes, E Man, J Thind, S Yeung, A Joy, C Hoskins Biomaterials science 8 (17), 4653-4664, 2020 | 358 | 2020 |
| Drug development: Lessons from nature S Mathur, C Hoskins Biomedical reports 6 (6), 612-614, 2017 | 276 | 2017 |
| On the issue of transparency and reproducibility in nanomedicine HS Leong, KS Butler, CJ Brinker, M Azzawi, S Conlan, C Dufès, A Owen, ... Nature nanotechnology 14 (7), 629-635, 2019 | 192 | 2019 |
| Hybrid gold-iron oxide nanoparticles as a multifunctional platform for biomedical application C Hoskins, Y Min, M Gueorguieva, C McDougall, A Volovick, P Prentice, ... Journal of nanobiotechnology 10, 1-12, 2012 | 162 | 2012 |
| The cytotoxicity of polycationic iron oxide nanoparticles: common endpoint assays and alternative approaches for improved understanding of cellular response mechanism C Hoskins, A Cuschieri, L Wang Journal of nanobiotechnology 10, 1-11, 2012 | 155 | 2012 |
| Application of nanoparticle technologies in the combat against anti-microbial resistance M Kumar, A Curtis, C Hoskins Pharmaceutics 10 (1), 11, 2018 | 129 | 2018 |
| The use of nanotechnology in cardiovascular disease M Chandarana, A Curtis, C Hoskins Applied Nanoscience 8, 1607-1619, 2018 | 119 | 2018 |
| Resilient and agile engineering solutions to address societal challenges such as coronavirus pandemic S Goel, S Hawi, G Goel, VK Thakur, A Agrawal, C Hoskins, O Pearce, ... Materials Today Chemistry 17, 100300, 2020 | 116 | 2020 |
| Poly-l-lysine-coated magnetic nanoparticles as intracellular actuators for neural guidance C Riggio, MP Calatayud, C Hoskins, J Pinkernelle, B Sanz, TE Torres, ... International journal of nanomedicine, 3155-3166, 2012 | 110 | 2012 |
| Dilemmas in the reliable estimation of the in-vitro cell viability in magnetic nanoparticle engineering: which tests and what protocols? C Hoskins, L Wang, WP Cheng, A Cuschieri Nanoscale research letters 7, 1-12, 2012 | 109 | 2012 |
| Synthesis and characterization of TPGS–gemcitabine prodrug micelles for pancreatic cancer therapy V Khare, WA Sakarchi, PN Gupta, ADM Curtis, C Hoskins Rsc Advances 6 (65), 60126-60137, 2016 | 68 | 2016 |
| Dietary geranylgeraniol can limit the activity of pitavastatin as a potential treatment for drug-resistant ovarian cancer E de Wolf, MI Abdullah, SM Jones, K Menezes, DM Moss, FP Drijfhout, ... Scientific reports 7 (1), 5410, 2017 | 65 | 2017 |
| The use of iron oxide nanoparticles for pancreatic cancer therapy M Malekigorji, ADM Curtis, C Hoskins Journal of Nanomedicine Research 1 (1), 1-12, 2014 | 63 | 2014 |
| Stimuli responsive polymeric systems for cancer therapy A Alsuraifi, A Curtis, DA Lamprou, C Hoskins Pharmaceutics 10 (3), 136, 2018 | 60 | 2018 |
| Neuronal cells loaded with PEI-coated Fe 3 O 4 nanoparticles for magnetically guided nerve regeneration MP Calatayud, C Riggio, V Raffa, B Sanz, TE Torres, MR Ibarra, ... Journal of Materials Chemistry B 1 (29), 3607-3616, 2013 | 57 | 2013 |
| Nanotechnologies in pancreatic cancer therapy A Manzur, A Oluwasanmi, D Moss, A Curtis, C Hoskins Pharmaceutics 9 (4), 39, 2017 | 56 | 2017 |
| Liposome-based diagnostic and therapeutic applications for pancreatic cancer F Raza, L Evans, M Motallebi, H Zafar, M Pereira-Silva, K Saleem, ... Acta Biomaterialia 157, 1-23, 2023 | 54 | 2023 |
| The biological challenges and pharmacological opportunities of orally administered nanomedicine delivery DM Moss, P Curley, H Kinvig, C Hoskins, A Owen Expert Review of Gastroenterology & Hepatology 12 (3), 223-236, 2018 | 48 | 2018 |
| Diels Alder-mediated release of gemcitabine from hybrid nanoparticles for enhanced pancreatic cancer therapy A Oluwasanmi, W Al-Shakarchi, A Manzur, MH Aldebasi, RS Elsini, ... Journal of Controlled Release 266, 355-364, 2017 | 45 | 2017 |
| Poly (vinyl alcohol) and functionalized ionic liquid-based smart hydrogels for doxorubicin release M Kuddushi, D Ray, V Aswal, C Hoskins, N Malek ACS applied bio materials 3 (8), 4883-4894, 2020 | 44 | 2020 |
